Deferred Tax Assets, Valuation Allowance of Kiniksa Pharmaceuticals International, plc from 31 Dec 2016 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Kiniksa Pharmaceuticals International, plc quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2016 to 31 Dec 2025.
  • Kiniksa Pharmaceuticals International, plc Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $666,461,000, a 1.5% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Kiniksa Pharmaceuticals International, plc Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $666,461,000 +$9,749,000 +1.5% 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q4 2024 $656,712,000 +$610,452,000 +1320% 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q4 2023 $46,260,000 +$26,676,000 +136% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q4 2022 $19,584,000 -$108,360,000 -85% 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q4 2021 $127,944,000 +$118,637,000 +1275% 31 Dec 2021 10-K 28 Feb 2024 2023 FY
Q4 2020 $9,307,000 +$8,977,000 +2720% 31 Dec 2020 10-K 02 Mar 2023 2022 FY
Q1 2020 $5,410,000 31 Mar 2020 10-Q 04 May 2020 2020 Q1
Q4 2019 $330,000 +$281,000 +573% 31 Dec 2019 10-K 02 Mar 2023 2022 FY
Q4 2018 $49,000 +$22,000 +81% 31 Dec 2018 10-K 24 Feb 2022 2021 FY
Q4 2017 $27,000 -$9,973,000 -100% 31 Dec 2017 10-K 25 Feb 2021 2020 FY
Q4 2016 $10,000,000 31 Dec 2016 10-K 12 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.